News & Media

In The News

January 5, 2024

Infinimmune, Grid Therapeutics Strike Antibody-Based Cancer Drug Discovery Partnership

April 19, 2023

Bio’s Next Tool Builders

March 28, 2023

Spotlight on Infinimmune

March 24, 2023

Founding Infinimmune and Developing Breakthrough Tools for Antibody Discovery

December 6, 2022

Infinimmune’s secret for building better antibody drugs: You

December 6, 2022

$12-Million Seed Funding to Design Drugs Using Human-Sourced Antibodies


There are no events scheduled at this time.

Press Releases

Infinimmune Announces Partnership with Grid Therapeutics to Conduct Deep Sequencing of B Cells for Oncology Drug Discovery

December 19, 2023

"Infinimmune, a biotechnology company pioneering new methods for antibody drug discovery and development, today announced a partnership with Grid Therapeutics (“Grid”), a clinical stage biotechnology company that focuses on human-derived antibodies, to collaborate in identifying new antibody drug candidates for non-small cell lung cancer."

Infinimmune Raises $12 Million in Seed Funding

December 6, 2022

"Infinimmune combines a world-class team of technologists with a state-of-the-art platform for the discovery, characterization, and validation of truly human antibodies,” said Eddie Eltoukhy, Partner at Pear VC.